Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Century Therapeutics Q3 EPS $(0.55) Misses $(0.51) Estimate, Sales $148.00K Miss $1.16M Estimate

Author: Benzinga Newsdesk | November 09, 2023 08:46am
Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 3.77 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $148.00 thousand which missed the analyst consensus estimate of $1.16 million by 87.24 percent. This is a 93.35 percent decrease over sales of $2.22 million the same period last year.

Posted In: IPSC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist